Implementation Guidelines - Federal Transit Administration - U.S. ...

acceptable for the company-required blood or hair specimen to be supported by the same
custody and control form that accompanies a DOT-required urine specimen.
Under no circumstances can the results of the blood or hair test be used to take administrative
or disciplinary action against an employee using DOT authority for the reasons cited above.
Q. How and to whom are drug testing custody and control forms distributed?
A. The only acceptable procedures for handling the custody and control form as specified in 49
CFR part 40 (§40.73) are as follows: Parts 1 must accompany the urine specimen in a sealed
container to the laboratory; Part 2 (MRO) must be sent from the collection site directly to the
physician (MRO); Part 3 is retained by the collection site personnel; and Part 4 is provided to
the employer representative, and Part 5 is given to the donor at the collection site.
Q. Must the collector provide a real name on the collector certification section of drug
testing custody and control form?
A. The intent of the DOT drug testing custody form is to provide complete documentation of the
specimen collection process, including the name of the collector and the location of the
collection site. The collection site person who receives the urine specimen from the donor
should be identified by name on the block specifying “collector’s name.” Use of a “code
name,” collector I.D. number, or other substitution for the collector’s name is not acceptable.
The collector’s name should be the same as that appearing on the identification each collector
is required to make available to the donor, if so requested.
Q. Are middle names required on the drug testing custody and control form?
A. 49 CFR part 40, Procedures for Transportation Workplace Drug Testing Programs, specifies
that the custody and control form used to document DOT-mandated drug testing shall
provide space for collector, donor, and laboratory certifying scientist names and signatures.
The regulation does not specify that a middle name must be used. The intent of the
regulation is to provide for the identification of the person(s) signing the certification
statements. The use of supplemental instructions on the custody and control form (e.g.
further defining name to include first, middle, last), does not impact on the security,
identification, or integrity of the urine specimen and should not be used as a basis for
invalidating the specimen results.
Q. Is the MRO name required on the drug testing custody and control form? Can the
MRO’s company name be used instead?
A. The regulation, 49 CFR Part 40.45 (c) (2), specifies that the MRO information must include
the specific physician’s name and address, as opposed to only a generic clinic, health care
organization, or company name.
Appendix G. Questions and Answers G-10 August 2002